logo

Valeritas Holdings, Inc (VLRX)



Trade VLRX now with
  Date
  Headline
7/8/2019 7:11:08 AM Valeritas Announces Positive Data From A Retrospective Study
6/27/2019 7:24:28 AM Valeritas Files Special 510(k) For Labeling Change To Include Use Of RHI In V-Go® Wearable Insulin Delivery Device
6/24/2019 7:19:04 AM Valeritas Reports Sale Of Over 20 Mln V-Go Insulin Delivery Devices In US
5/17/2019 7:05:51 AM Valeritas Holdings Declares 1-for-20 Reverse Stock Split
3/5/2019 4:17:48 PM Valeritas Holdings Q4 Loss/share $0.20 Vs. Loss $3.10 Year Ago
1/14/2019 7:02:34 AM Valeritas Announces That V-Go Is Preferred On The OptumRx Formulary
11/15/2018 8:35:22 PM Valeritas Announces Pricing Of $36 Mln Public Offering
11/9/2018 7:18:53 AM Valeritas Holdings Q3 Net Loss Widens To $11.5 Mln From $10.6 Mln Last Year
8/23/2018 7:06:51 AM Valeritas Unveils V-Go® Insulin Delivery Device In Australia
6/25/2018 7:06:15 AM Valeritas Holdings Announces Positive Results From ENABLE Study
5/21/2018 7:05:19 AM Valeritas Signs Exclusive Distribution Agreement With MED TRUST
5/18/2018 7:05:20 AM Valeritas Reports Positive Clinical Results Across Two New Studies Evaluating V-Go Wearable Insulin Delivery Device
4/30/2018 7:18:24 AM Valeritas Presented Positive New Data Demonstrating Use Of V-Go® Wearable Insulin Delivery Device Results
4/24/2018 7:04:56 AM Valeritas Holdings Announces Pricing Of $24 Mln Public Offering Of Common Stock
4/17/2018 7:02:49 AM Valeritas Inks Deal For Commercialization Of V-Go® Wearable Insulin Delivery Device In Australia And New Zealand